Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)
PHASE3
Multicenter, open-label, randomized, controlled phase III clinical trial to...
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
PHASE3
Small cell lung cancer (SCLC) is characterized by aggressive and rapid grow...
Status
Recruiting
Location
Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063
A Study of ZL-1310 in Combination With a Checkpoint Inhibitor Versus Standard of Care Platinum Based Chemotherapy With a Checkpoint Inhibitor as First-line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer
PHASE3
The purpose of this study is to evaluate the efficacy and safety of ZL-1310...